ACCP Pediatric & Maternal Clinical Pharmacology Community
Are you interested in the rapidly evolving field of pediatrics and maternal research, drug discovery and clinical trials? Enhance your network and make an impact by joining the ACCP Pediatric & Maternal Clinical Pharmacology Community, ACCP’s inaugural initiative to develop Communities of clinical pharmacology professionals with similar interests and objectives.
The ACCP Pediatric & Maternal Clinical Pharmacology Community will promote the principles of clinical pharmacology across the greater team of pediatric and maternal health professionals, plus educate young healthcare professionals and the public. This may include developing educational training events in the form of webinars, ACCP Annual Meeting Proposals or proposals for other global meetings; developing manuscripts, white papers or other opinions for publication and working to achieve the harmonization of the US with global pediatric and maternal clinical pharmacology agendas. ACCP seeks to become a trusted voice through outreach within the global clinical pharmacology community as well as the public at large.
Drs. Natella Rakhmanina and Jeremiah Momper shared, “We are thrilled to support the newly launched the ACCP Pediatric & Maternal Clinical Pharmacology Community at ACCP. Significant advancements in the development and dosing of medications for newborns, infants, children and pregnant and lactating women have been achieved in recent years. However, multiple gaps remain which limit our ability to effectively address health, growth and developmental needs in these complex patient populations. Bringing together researchers and the broader community interested in advancing the agenda for pediatric and maternal clinical pharmacology will allow us to strengthen networks and collaborations. We hope this initiative will draw interest among ACCP members and beyond and will link us closer to the populations we serve.”
Community Membership
Community membership should be representative of ACCP’s membership and should therefore include representation from academia, industry, clinical and regulatory agencies, as well as MDs, PharmDs and PhDs or other degreed individuals associated with the healthcare professions and biomedical or pharmaceutical sciences. Students & Trainees are strongly encouraged to participate in the community.
Community Goals
The ACCP Pediatric & Maternal Clinical Pharmacology Community activities include, but are not limited to, the following:
- Establish regular meetings of the Community on a schedule, the frequency and timing of which is established by the Community to optimize participation and productivity;
- Contribute to the exchange of knowledge and collegial support on the topics of pediatric and maternal clinical pharmacology;
- Development of educational proposals for webinars, the ACCP Annual Meeting or other global clinical pharmacology-focused, pediatric-focused or maternal-focused meetings;
- Serve as a forum for facilitating collaborative research efforts in the areas of pediatric and maternal health;
- Development of educational proposals for webinars, the ACCP Annual Meeting or other global clinical pharmacology-focused, pediatric-focused or maternal-focused meetings;
- Development of white papers, opinions or other forms of manuscripts for publication in ACCP journals and/or other pediatric, maternal or clinical-pharmacology-focused journals;
- Development of materials for the education of the public;
- Collaborate with ACCP Staff to develop content for the ACCP1.org website, social media, brief videos and press releases as required about the Community’s activities;
- Advocacy for the optimization of pediatric and maternal drug therapies;
- Respond to guidances and engage with regulatory agencies on issues related to pediatric and maternal clinical pharmacology.